TITLE

Cancer Incidence in New York State Acquired Immunodeficiency Syndrome Patients

AUTHOR(S)
Gallagher, Brian; Zhengyan Wang; Schymura, Maria J.; Kahn, Amy; Fordyce, E. James
PUB. DATE
September 2001
SOURCE
American Journal of Epidemiology;Sep2001, Vol. 154 Issue 6, p544
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
To identify cancers that occur at higher rates in acquired immunodeficiency syndrome (AIDS) patients, the cancer experience of New York State (NYS) AIDS patients aged 15–69 years who were diagnosed between 1981 and 1994 was compared with that of the NYS general population. Sex and HIV risk group-specific standardized incidence ratios (SIRs), post-AIDS relative risks, and trends of relative risks were calculated to determine cancer risk. Among non-AIDS-related cancers, elevated SIRs were found for Hodgkin's disease (male, 8.0; female, 6.4; heterosexually infected males, 31.3); cancer of the rectum, rectosigmoid, and anus (male, 3.3; female, 3.0); trachea, bronchus, and lung (male, 3.3; female, 7.5); and brain and central nervous system (male, 3.1; female, 3.4; heterosexually infected females, 23.8) cancers. Moreover, significant trends of increasing relative risks from the pre-AIDS to the post-AIDS period were found for cancers of the rectum, rectosigmoid, and anus; trachea, bronchus, and lung; skin; and connective tissues (all sites, p < 0.05) among males. For AIDS-related cancers in women, invasive cervical cancer had an overall SIR of 9.1 (95% confidence interval: 6.9, 10.8) and a post-AIDS relative risk of 6.5 (95% confidence interval: 4.1, 9.7). This population-based registry linkage analysis evaluates cancer risk in AIDS patients by sex and risk factors and adds evidence that HIV-associated immunosuppression increases the risks of specific types of cancer.
ACCESSION #
44594659

 

Related Articles

  • NUTRITION AND PATIENTS WITH HIV/AIDS. Stojanović, Dušica; Marković, Danica; Kocić, Gordana // Acta Medica Medianae;Sep2011, Vol. 50 Issue 3, p63 

    Immune status of an individual depends on the organism's nutritional status as well as on the choice of nutrients that enter the body. Malnutrition and HIV progression are closely linked and require an active cooperation between infectious disease physicians and nutritionist. It has been noticed...

  • Antibiotic gets star role as HIV wonder drug. Coghlan, Andy // New Scientist;11/27/2004, Vol. 184 Issue 2475, p8 

    The article discusses the use of cotrimoxazole in the treatment of lethal respiratory infections in AIDS patients. Cotrimoxazole last week earned a new and heroic role in the fight against childhood AIDS in Africa, preventing potentially lethal respiratory infections that strike HIV-positive...

  • Dysregulated Immune Activation in Second-Line HAART HIV+ Patients Is Similar to That of Untreated Patients. Espíndola, Milena S.; Lima, Leonardo J. G.; Soares, Luana S.; Cacemiro, Maira C.; Zambuzi, Fabiana A.; de Souza Gomes, Matheus; Amaral, Laurence R.; Bollela, Valdes R.; Martins-Filho, Olindo A.; Frantz, Fabiani G. // PLoS ONE;12/18/2015, Vol. 10 Issue 12, p1 

    Background: Successful highly active antiretroviral therapy (HAART) has changed the outcome of AIDS patients worldwide because the complete suppression of viremia improves health and prolongs life expectancy of HIV-1+ patients. However, little attention has been given to the immunological...

  • HIV-1 Drug Resistance Profiles in Children and Adults With Viral Load of greater than 50 Copies/mL Receiving Combination Therapy. Hermankova, Monika; Ray, Stuart C.; Ruff, Christian; Powell-Davis, Monique; Ingersoll, Roxann; D'Aquila, Richard T.; Quinn, Thomas C.; Siliciano, Janet D.; Siliciano, Robert F.; Persaud, Deborah // JAMA: Journal of the American Medical Association;7/11/2001, Vol. 286 Issue 2, p196 

    Presents a study to determine genetic resistance profiles of low-level plasma HIV-1 in patients with prolonged viral suppression while receiving highly active antiretroviral therapy. Design and setting; Patients; Main outcome measure; Results; Conclusions.

  • Low-Level Viremia and Proviral DNA Impede Immune Reconstitution in HIV-1--Infected Patients Receiving Highly Active Antiretroviral Therapy. Ostrowski, Sisse R.; Katzenstein, Terese L.; Thim, Per T.; Pedersen, Bente K.; Gerstoft, Jan; Ullum, Henrik // Journal of Infectious Diseases;2/1/2005, Vol. 191 Issue 3, p348 

    Background. Immunological and virological consequences of low-level viremia in human immunodeficiency virus (HIV) type 1-infected patients receiving highly active antiretroviral therapy (HAART) remain to be determined. Methods. For 24 months, 101 HAART-treated, HIV-1-infected patients with HIV...

  • Hodgkin's lymphoma in an HIV-positive man. Blaes, Anne // Hem/Onc Today;12/25/2008, Vol. 9 Issue 23, p14 

    The article describes the case of Hodgkin's lymphoma in a human immunodeficiency virus (HIV)-positive man. Hodgkins lymphoma is increased in persons with HIV/acquire immune deficiency syndrome (AIDS). Risks are increased from fivefold to 15-fold. Hodgkin's lymphoma is more common among...

  • The Probable Source of Both the Primary Multidrug-Resistant (MDR) HIV-1 Strain Found in a Patient with Rapid Progression to AIDS and a Second Recombinant MDR Strain Found in a Chronically HIV-1—Infected Patient. Blick, Gary; Kagan, Ron M.; Coakley, Eoin; Petropoulos, Christos; Maroldo, Laura; Greiger-Zanlungo, Paola; Gretz, Scott; Garton, Trish // Journal of Infectious Diseases;5/1/2007, Vol. 195 Issue 9, p1250 

    Background. Rapid progression to AIDS after acute infection with a multidrug-resistant (MDR), dual-tropic strain of human immunodeficiency virus type 1 (HIV-1) was reported in a New York City man (hereafter referred to as ‘NYC’) who has sex with men. The probable source of this...

  • The Epidemic Comes Home: b. The Ethical Dimension: "Don't Tell Me on Friday". Richards, Thomas // AIDS Reader (Branden Publishing);1988, p232 

    The article presents a reprint of the article "Don't Tell Me on Friday," by Thomas Richards, which appeared on the April 5, 1986 issue of the British Medical Journal. The author relates his experience on being positive for antibodies to human T cell lymphotropic virus III. He was shocked upon...

  • Risk of Cancer among Commercially Insured HIV-Infected Adults on Antiretroviral Therapy. Lee, Jeannette Y.; Dhakal, Ishwori; Casper, Corey; Noy, Ariela; Palefsky, Joel M.; Haigentz, Missak; Krown, Susan E.; Ambinder, Richard F.; Mitsuyasu, Ronald T. // Journal of Cancer Epidemiology;11/2/2016, p1 

    The objective of this study was to explore the cancer incidence rates among HIV-infected persons with commercial insurance who were on antiretroviral therapy and compare them with those rates in the general population. Paid health insurance claims for 63,221 individuals 18 years or older, with...

Share

Read the Article

Courtesy of NEW JERSEY STATE LIBRARY

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics